Director/PDMR Shareholding

RNS Number : 4826P

AstraZeneca PLC

25 March 2009

 



Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

We hereby inform you that on 24 March 2009, the interest of the following individuals, who are all persons discharging managerial responsibilities, in AstraZeneca PLC Ordinary Shares of $0.25 each, changed as detailed below. The change in interest relates to the vesting of previously announced awards made in March 2006 under the AstraZeneca Performance Share Plan or, for Jeff Pott and Lynn Tetrault, the AstraZeneca Executive Performance Share Plan, whereby, following the application of performance measures specified at the time of grant, the individuals concerned have now become beneficially entitled to a percentage of the shares originally awarded. In accordance with the plan rules, the unvested part of the award has immediately and irrevocably lapsed. In each case, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting. The interests of Jeff Pott, Lynn Tetrault and Tony Zook are in the Company's American Depositary Shares (ADSs). One ADS equals one Ordinary Share.

Name	Number of Shares Awarded	Vesting Percentage	Number of Shares Lapsed	Number of Shares Vested	Number of Shares Withheld	Net Number of Shares
Bruno Angelici	26,781	89%	2,946	23,835	9,773	14,062
Jan Lundberg	18,475	89%	2,032	16,443	9,537	6,906
Jeff Pott	2,020	75%	505	1,515	490	1,025
Lynn Tetrault	4,221	75%	1,055	3,166	1,025	2,141
Tony Zook	37,624	89%	4,139	33,485	14,197	19,288

The market price of AstraZeneca PLC Ordinary Shares of $0.25 each on 24 March 2009 was 2287 pence. The market price of AstraZeneca ADSs on 24 March 2009 was $33.31.

A C N Kemp

Company Secretary

25 March 2009

 

END

 

 

RDSUVSVRKNROUAR